Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre.

Abstract

Although HCV infection affects a minority of long term survivors of haematological malignancy, infected patients may benefit from alpha-interferon treatment. The screening of all patients treated for haematological malignancy before September 1991 is advocated.